[ Price : $8.95]
FDA approves Lumicells Lumisight to assist in the detection of cancerous tissue in breast cancer patients undergoing a lumpectomy....[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Orchard Therapeutics for its rare pediatric disease drug approval...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Expedited Programs for Serious Conditions ...[ Price : $8.95]
CDER Office of Medical Policy regulatory counsel Christopher Diamant explains why the new Patient Medication Information form was ...[ Price : $8.95]
Two Polsinelli attorneys say the Supreme Courts refusal to hear an appeal in a labeling case helps manufacturers argue for preempt...[ Price : $8.95]
Patient nonprofit group Haystack Project confirms that former FDA principal deputy commissioner Janet Woodcock is playing an advis...[ Price : $8.95]
PhRMA gives FDA general and specific comments on a draft guidance on using data monitoring committees in clinical trials.[ Price : $8.95]
FDA approves a Genentech NDA for Alecensa (alectinib) for adjuvant treatment following tumor resection for patients with anaplasti...